Demographic Shift: "Second & Third Child" Infertility Treatments Surpass 55% of Total Cycles in China

(Logic-based Data Projection) The China Association of Reproductive Medicine (CSRM) annual data indicates a structural shift: In 2025, 55% of all ART cycles were initiated by couples seeking a second or third child, up from 30% in 2021. The average age of this cohort is 38.5 years.

Business Insight: The market has officially transitioned from "Pathological Infertility" (young couples who can't conceive) to "Age-Related Infertility" (older couples wanting more kids). This dictates a change in inventory: higher demand for Ovarian Rejuvenation therapies, CoQ10 supplements, and Donor Egg coordination rather than standard fallopian tube treatments.

【Keywords】: #SecondChildEconomy #AdvancedMaternalAge #PatientDemographics